Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

por Schultz, Neil M., O’Day, Ken, Sugarman, Rebecca, Ramaswamy, Krishnan
Publicado 2020

Evaluating the Presence of Cognitive Biases in Health Care Decision Making: A Survey of U.S. Formulary Decision Makers

por Mezzio, Dylan J., Nguyen, Victor B., Kiselica, Andrew, O’Day, Ken
Publicado 2018

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

por O’Day, Ken, Rajagopalan, Krithika, Meyer, Kellie, Pikalov, Andrei, Loebel, Antony
Publicado 2013

Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA

por O’Day, Ken, Levy, Wayne C., Johnson, Meridith, Jacobson, Arnold F.
Publicado 2016

Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States

por Mody, Reema R., Meyer, Kellie L., Ward, Jennifer M., O’Day, Ken B.
Publicado 2023

The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based p...

por Campbell, David, O’Day, Ken, Hertel, Nadine, Penrod, John R., Manley Daumont, Melinda, Lees, Michael
Publicado 2018

Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

por Bui, Cat N., O’Day, Ken, Flanders, Scott, Oestreicher, Nina, Francis, Peter, Posta, Linda, Popelar, Breanna, Tang, Hong, Balk, Mark
Publicado 2016